Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Wesana Health Holdings Inc. (C:WESA)

Business Focus: Biotechnology & Medical Research (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for WESA within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 01, 2022 19:14 ET
Wesana Announces Sale of Clinic Management Services Organization
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow, today announces that it successfully completed a transaction (the “Sale...
Read full article
Aug 29, 2022 20:00 ET
Wesana Announces Second Quarter 2022 Financial Results
Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, has today announced its second...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.56
--
--
Price to Sales - TTM
2.79
7.70
4.47
Price to Book - most recent quarter
0.28
1.94
1.67
Price to Cash Flow per share - TTM
--
10.27
9.11
Price to Free Cash Flow per share - TTM
--
24.16
12.54
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 202264,08163,151
Oct 31, 2022930-53,593
Oct 15, 202254,52354,363
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Wesana Health Holdings Inc is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain Injury related depressive disorder, anxiety and migraines through drug development and predictive diagnostics. The Company is also engaged in care development through its therapies and patent-pending protocols, and in care delivery through activating a multidisciplinary, technology-supported clinical model. Its SANA-013 is a novel composition and method of use that provides sustained effects and benefit over time. The Company's novel and proprietary depression treatment protocol that includes a single high dose of psilocybin followed by a maintenance regimen of a micro dose of psilocybin combined with cannabidiol, significantly reduced depressive behaviors in a validated animal model.

See business summary

 

Twitter

Search (past week) for $WESA.CA

  • No tweets found